Search Results - Ashry, Tameem

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Anti‐PD‐1/PD‐L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer

    Anti‐PD‐1/PD‐L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer by Gunda, Viswanath, Gigliotti, Benjamin, Ashry, Tameem, Ndishabandi, Dorothy, McCarthy, Michael, Zhou, Zhiheng, Amin, Salma, Lee, Kyu Eun, Stork, Tabea, Wirth, Lori, Freeman, Gordon J., Alessandrini, Alessandro, Parangi, Sareh

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo

    Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo by Kolkhir, Pavel, Pyatilova, Polina, Ashry, Tameem, Jiao, Qingqing, Abad-Perez, Angela Teresa, Altrichter, Sabine, Vera Ayala, Carolina Elisa, Church, Martin K., He, Jiajun, Lohse, Katharina, Metz, Martin, Scheffel, Jörg, Türk, Murat, Frischbutter, Stefan, Maurer, Marcus

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity

    The Number of MRGPRX2-Expressing Cells Is Increased in Skin Lesions of Patients With Indolent Systemic Mastocytosis, But Is Not Linked to Symptom Severity by Pyatilova, Polina, Ashry, Tameem, Luo, Yanyan, He, Jiajun, Bonnekoh, Hanna, Jiao, Qingqing, Moñino-Romero, Sherezade, Hu, Man, Scheffel, Jörg, Frischbutter, Stefan, Hermans, Maud A. W., Youngblood, Bradford A., Maurer, Marcus, Siebenhaar, Frank, Kolkhir, Pavel

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer

    Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer by Gunda, Viswanath, Gigliotti, Benjamin, Ndishabandi, Dorothy, Ashry, Tameem, McCarthy, Michael, Zhou, Zhiheng, Amin, Salma, Freeman, Gordon J., Alessandrini, Alessandro, Parangi, Sareh

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: